Hospital Pharmacy Europe

DECEMBER 5, 2024

2024 was a transformative year in pharmacy and therapeutics, marked by groundbreaking advances that promise lasting impacts on healthcare. Dr João Gonçalves PhD presents his pick for this year’s top five pharmacy innovations, illustrating how they set new standards for patient care and pharmaceutical development.

Vaccines 59

Vaccines Patient Care Compounding Pharmaceutical Companies 59

STAT

JULY 6, 2023

On one side is the Pharmaceutical Care Management Association, the trade association representing pharmacy benefit managers, which argues that pharmaceutical companies are responsible for high drug prices. The company hopes to launch the product in the U.S. in 2024.

Vaccines 93

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 93

The Checkup by Singlecare

SEPTEMBER 10, 2024

Stelara biosimilar availability As of July 2024, several biosimilars have been approved by the FDA but are not expected to be available until late February 2025, due to settlements and licensing agreements with Janssen Biotech, the manufacturer of Stelara. It is made by the pharmaceutical company Amgen, Inc.

FDA 52

FDA Vaccines Specialty Pharmacies Pharmaceutical Companies 52

pharmaphorum

FEBRUARY 16, 2022

June 2021 saw more emerge on their ambitions, with the publication of their Strategic Plan 2021-2024 focusing on agility and international alignment, with the aim to speed up regulatory approval. Ensuring wider use of new medicines is what will make the UK market really attractive to pharmaceutical companies.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

Pharmaceutical Technology

SEPTEMBER 26, 2022

Both Sandoz and Novartis are internationally renowned pharma companies, with a combined 34 production facilities worldwide. These highlight the parent company’s focus on innovative and high-value drug development. The company had revenues of $9.6bn both in 2020 and last year. The site employs around 250 people.

Vaccines 64

Vaccines Dosage Pharmaceutical Companies Pharmaceutical Companies 64

The Guardian - Pharmaceutical Industry

FEBRUARY 5, 2025

Pharmaceuticals companys higher dividend, upgrade to revenues and share buyback suggest its drugs pipeline is flowing nicely You could have made good money during Dame Emma Walmsleys eight years as chief executive of GlaxoSmithKline by buying the shares whenever they fell to 13 and shorting them whenever they hit 18.

Pharmaceutical Companies 44

Pharmaceutical Companies Pharmaceutical Companies Vaccines 44

The Checkup by Singlecare

JUNE 6, 2024

This law enables Medicare to negotiate directly with pharmaceutical companies, which should ultimately result in lower prescription drug costs for consumers. The normal counter price of generic Farxiga was $782 for 30, 10 mg tablets in May of 2024, compared to $800.29 for brand-name Farxiga.

Insurance 52

Insurance Hospitals Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

AUGUST 29, 2024

5 Preventing spread of the mpox virus To help prevent more cases of the virus, the CDC recommended that individuals who have had exposure to the virus and those at risk of infection are given two doses of biotech Bavarian Nordic’s vaccine JYNNEOS ® (MVA-BN).

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Immunization 98